GlassScriptPhysician profile
Jonathon Scott Egbert
NPI 1699069542
$4,449.69
in general payments reported to CMS, 2019-2025
6 companies · $217 in 2025
The $217 reported for 2025 was more than what 78% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $694 · 2021: $1,903 · 2022: $698 · 2023: $70.91 · 2024: $111 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174 · Entertainment: $154 · Education: $70.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.09 |
| Entertainment | $153.95 |
| Education | $70.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $2,153.45 | 2019-2025 | |
| Southern Implants North America INC | $1,945.69 | 2019-2021 | |
| Biohorizons Implant Systems INC. | $173.03 | 2019-2022 | |
| Straumann USA LLC | $111.30 | 2024 | |
| Peter Brasseler Holdings, LLC | $41.87 | 2020 | |
| Carestream Dental, LLC | $24.35 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Egbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.